comparemela.com
  1. Home
  2. Live Updates
  3. CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D) : comparemela.com

CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D)

CinPhloro Pharma, a CinRx Portfolio Company, Dosed First Participant in Phase 2 enviva Study of CIN-103 for Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Cincinnati ,Ohio ,Cinphloro Pharma ,Darren Brenner ,Cinrx Pharma ,Jason Westerheide ,Jon Isaacsohn ,Cassidy Mcclain ,Business Development ,Linkedin ,Phloro Pharma ,Chief Executive Officer ,Gastroenterology Medicine ,Northwestern University ,Feinberg School ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.